Tenax Therapeutics (TENX)

Tenax Therapeutics Stock Analysis & Ratings

TENX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.23 - $2.05
Previous Close$0.32
Average Volume (3M)104.14K
Market CapN/A
Enterprise ValueN/A
P/E Ratio-0.7
Next EarningsAug 16, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Tenax Therapeutics’s price range in the past 12 months?
Tenax Therapeutics lowest stock price was $0.23 and its highest was $2.05 in the past 12 months.
    What is Tenax Therapeutics’s market cap?
    Currently, no data Available
    What is Tenax Therapeutics’s price target?
    Currently, no data Available
    What do analysts say about Tenax Therapeutics?
    Not enough analysts have published a price target to provide an average price target.
    When is Tenax Therapeutics’s upcoming earnings report date?
    Tenax Therapeutics’s upcoming earnings report date is Aug 16, 2022 which is in 41 days.
      How were Tenax Therapeutics’s earnings last quarter?
      Tenax Therapeutics released its earnings results on Mar 31, 2022. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.16 by $0.05.
        Is Tenax Therapeutics overvalued?
        According to Wall Street analysts Tenax Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Tenax Therapeutics pay dividends?
          Tenax Therapeutics does not currently pay dividends.
          What is Tenax Therapeutics’s EPS estimate?
          Tenax Therapeutics’s EPS estimate is -$0.09.
            How many shares outstanding does Tenax Therapeutics have?
            Tenax Therapeutics has 25,206,915 shares outstanding.
              What happened to Tenax Therapeutics’s price movement after its last earnings report?
              Tenax Therapeutics reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.16. Following the earnings report the stock price went down -2.41%.
                Which hedge fund is a major shareholder of Tenax Therapeutics?
                Currently, no hedge funds are holding shares in TENX


                Tenax Therapeutics Stock Analysis

                Smart Score
                Not Ranked
                Price Target
                No data currently available
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Tenax Therapeutics

                Tenax Therapeutics, Inc. is a pharmaceutical company, which engages in the identification, development, and commercialization of novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.

                Similar Stocks
                Price & Change
                Protara Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis